Annual Reports in Medicinal Chemistry
Annual Reports in Medicinal Chemistry
6 ½ X 9 7/16 in I. CENTRAL NERVOUS SYSTEM DISEASES (A.J. Robichaud).
1 . Novel approaches for the treatment of schizophrenia (B.N. Rogers, C.J . Schmidt).
Recent strategies for the development o f new antidepressant drugs (D.A. Evrard).
Neuroprot ective agents for the treatment of ischemic and hemorrhagic stroke (S.N. Haydar, W.D. Hirst).
Novel sodium channel blocker s for the treatment of neuropathic pain (B. Marron).
II. CARDIOVASCULAR AND METABOLIC DISEASES (A. Stamford).
Centrally acting anti-obesity agents (D. Hepworth et al.).
Nuclear Hormone Receptor Modulat ors for the Treatment of Diabetes and Dyslipidemia (P.T. Meinke et a l.).
11 -Hydroxysteroid Dehydrogenase T ype 1 Inhibitors (C.D. Boyle et al.).
Glu cokinase Activators for the Treatment of Type 2 Diabetes (P.S. Humphries , T.O. Johnson).
Renin Inhibitors (C.M. Tice).
Antiarryhthmic Agents (M.J. Suto, D.S. Krafte).
This item is not currently in-stock. It can be ordered online and is expected to ship in approx 2 weeks
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.